MedPath

DEFERASIROX ABDI 180 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

DEFERASIROX ABDI 180 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

Pending
Register Number

87278

Prescription Type

Diagnóstico Hospitalario

Authorization Date

Jul 21, 2022

Dosage Form

COMPRIMIDO RECUBIERTO CON PELÍCULA

Route: VÍA ORAL

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number87278
EMA Approved
No

Drug Classification

Generic
Yes
Orphan
No
Biosimilar
No
Commercialized
No
CIMA AEMPS Classification

INGREDIENTS (1)

DEFERASIROXActive
Quantity: 180 mg
Name: DEFERASIROX

ATC CLASSIFICATION (2)

V03AC
V03AC03

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.